Role of Drug-coated Balloons in Small-vessel Coronary Artery Disease
Percutaneous coronary intervention of small-vessel coronary artery disease (SVD) remains challenging due to difficulties with device delivery and high restenosis rate, even with the use of newer-generation drug-eluting stents. Drug-coated balloons represent an attractive emerging percutaneous corona...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2019-01-01
|
| Series: | US Cardiology Review |
| Online Access: | https://www.uscjournal.com/articleindex/usc.2019.4.1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850110421472641024 |
|---|---|
| author | Michael Megaly Marwan Saad Emmanouil S Brilakis |
| author_facet | Michael Megaly Marwan Saad Emmanouil S Brilakis |
| author_sort | Michael Megaly |
| collection | DOAJ |
| description | Percutaneous coronary intervention of small-vessel coronary artery disease (SVD) remains challenging due to difficulties with device delivery and high restenosis rate, even with the use of newer-generation drug-eluting stents. Drug-coated balloons represent an attractive emerging percutaneous coronary intervention option in patients with SVD. Potential advantages of drug-coated balloons in SVD include enhanced deliverability because of their small profile, avoidance of foreign-body implantation, and shorter duration of dual antiplatelet therapy. |
| format | Article |
| id | doaj-art-5fa0cc149b4b475c9d3140cdd71076aa |
| institution | OA Journals |
| issn | 1758-3896 1758-390X |
| language | English |
| publishDate | 2019-01-01 |
| publisher | Radcliffe Medical Media |
| record_format | Article |
| series | US Cardiology Review |
| spelling | doaj-art-5fa0cc149b4b475c9d3140cdd71076aa2025-08-20T02:37:50ZengRadcliffe Medical MediaUS Cardiology Review1758-38961758-390X2019-01-01131162010.15420/usc.2019.4.1Role of Drug-coated Balloons in Small-vessel Coronary Artery DiseaseMichael Megaly0Marwan Saad1Emmanouil S Brilakis2Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, MN; Division of Cardiovascular Medicine, Hennepin Healthcare, Minneapolis, MNDivision of Cardiovascular Medicine, Department of Medicine, University of Arkansas, Little Rock, AR; Department of Cardiovascular Medicine, Ain Shams University, Cairo, EgyptMinneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, MNPercutaneous coronary intervention of small-vessel coronary artery disease (SVD) remains challenging due to difficulties with device delivery and high restenosis rate, even with the use of newer-generation drug-eluting stents. Drug-coated balloons represent an attractive emerging percutaneous coronary intervention option in patients with SVD. Potential advantages of drug-coated balloons in SVD include enhanced deliverability because of their small profile, avoidance of foreign-body implantation, and shorter duration of dual antiplatelet therapy.https://www.uscjournal.com/articleindex/usc.2019.4.1 |
| spellingShingle | Michael Megaly Marwan Saad Emmanouil S Brilakis Role of Drug-coated Balloons in Small-vessel Coronary Artery Disease US Cardiology Review |
| title | Role of Drug-coated Balloons in Small-vessel Coronary Artery Disease |
| title_full | Role of Drug-coated Balloons in Small-vessel Coronary Artery Disease |
| title_fullStr | Role of Drug-coated Balloons in Small-vessel Coronary Artery Disease |
| title_full_unstemmed | Role of Drug-coated Balloons in Small-vessel Coronary Artery Disease |
| title_short | Role of Drug-coated Balloons in Small-vessel Coronary Artery Disease |
| title_sort | role of drug coated balloons in small vessel coronary artery disease |
| url | https://www.uscjournal.com/articleindex/usc.2019.4.1 |
| work_keys_str_mv | AT michaelmegaly roleofdrugcoatedballoonsinsmallvesselcoronaryarterydisease AT marwansaad roleofdrugcoatedballoonsinsmallvesselcoronaryarterydisease AT emmanouilsbrilakis roleofdrugcoatedballoonsinsmallvesselcoronaryarterydisease |